NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Zenflow

Zenflow

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.zenflow.com/

Last Round

Series C

Nov 18, 2024

Total Funding Raised

$89.6M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Zenflow is a medical device company that develops minimally invasive treatments for urinary obstruction caused by benign prostatic hyperplasia (BPH).

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

benign prostatic hyperplasiaBPHminimally invasive urologyurology medical deviceprostatic urethral implanturology implantoffice-based urologyurology surgeryurology procedureurology techmedical device manufacturerurology hardware

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zenflow Comps

Public and private peers based on sector, stage, and business model.

Zenflow comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Zenflow Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CNov 18, 2024
Series BJun 2, 2021
DebtNov 27, 2018
Series AFeb 7, 2018
SeedDec 31, 2017

Key People

Founding team and executive leadership

Shreya Mehta

Chief Executive Officer

Executive Team

Ronald Jabba

Chief Operating Officer

Executive Team

Zenflow Investors

Notable investors and investment history

Zenflow investors
InvestorRounds
StartXSeed
NIH RADxSeries A
F-Prime CapitalSeries C, Series B, Series A
Astia AngelsSeries B
Cloudstone CapitalSeries B
Medical Technology Venture PartnersSeries C, Series B, Series A
Invus OpportunitiesSeries C, Series B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2026

    Grew 20% QoQ, from 35 to 42 employees.

  • Oct 1, 2025

    Zenflow Spring System receives FDA approval for commercial sale.

Zenflow Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Zenflow Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Zenflow's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range42
Year Founded2014
Last FundingNov 18, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.